Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

Clinical guidelines for breast cancer treatment differ in their selection of patients at a high risk of recurrence who are eligible to receive adjuvant systemic treatment (AST). The 70-gene signature is a molecular tool to better guide AST decisions. The aim of this study was to evaluate whether add...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2014
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4031388/
https://ncbi.nlm.nih.gov/pubmed/24760482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2954-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados